Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

aviptadil

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
PurposeData assessing the effectiveness of intracavernosal injections (ICIs) for the treatment of erectile dysfunction (ED) are… Expand
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Review
2015
Review
2015
Biomedical advances over the last decade have identified the central role of proliferative pulmonary arterial smooth muscle cells… Expand
  • table 1
  • figure 1
Is this relevant?
2014
2014
Purification and quality control of therapeutic peptides is often performed by one single method, RP-HPLC. As usage of an… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2014
2014
Die Therapie der pulmonalen Hypertonie liefert nach wie vor keine zufriedenstellenden Ergebnisse.9 Deswegen ist es notig, weitere… Expand
Is this relevant?
Review
2011
Review
2011
Pulmonary arterial hypertension (PAH) consists of a group of heterogeneous but distinct disorders characterized by complex… Expand
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Pulmonary hypertension (PH) leads to an increased right ventricular workload, cardiac failure and death. In idiopathic pulmonary… Expand
Is this relevant?
Review
2008
Review
2008
Pulmonary arterial hypertension (PAH) is an orphan disease for which no specific pharmacological therapy was available until 1996… Expand
Is this relevant?
Review
2001
Review
2001
  • Garben Keijzers
  • Current opinion in investigational drugs
  • 2001
  • Corpus ID: 31527087
Aviptadil is an injectable formulation of vasoactive intestinal polypeptide (VIP) in combination with the adrenergic drug… Expand
Is this relevant?